The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study

MGT significantly increases genetic testing uptake among all eligible patients and across all SES subgroups, strongly encouraging further implementation of MGT. Educating HCPs about current disparities in genetic testing is essential to improve health equity in breast cancer care.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2025-07-13
DOI
https://doi.org/10.1186/s13058-025-02081-y
Citations
1
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study

Sabine Siesling, Ghita Carola Wilhelmina Maria Puts, Agnes Jager, Margreet G. E. M. Ausems et al.
1 citations
Breast Cancer Research
BRCA gene mutations in cancer
1.82
article

The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study

Sabine Siesling, Ghita Carola Wilhelmina Maria Puts, Agnes Jager, Margreet G. E. M. Ausems, C.L.D. de Jong
article en
1 citations

Abstract

MGT significantly increases genetic testing uptake among all eligible patients and across all SES subgroups, strongly encouraging further implementation of MGT. Educating HCPs about current disparities in genetic testing is essential to improve health equity in breast cancer care.

Breast Cancer ResearchVol. 27(1)
Utrecht University (NL), Heidelberg University (DE), University Hospital Heidelberg (DE), University Medical Center Utrecht (NL), Netherlands Comprehensive Cancer Organisation (NL), Erasmus MC Cancer Institute (NL), University of Twente (NL)
AstraZeneca
Openalex Percentile: Top 14%
BRCA gene mutations in cancer
1.82
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.